October 30, 2020
When Apple announced its Series 6 Watch wearable last month, with new features, including VO2 Max and blood oxygenation sensors, the tech giant also announced three new clinical studies that would use the device.
We expounded on one, an asthma study, in collaboration with Anthem, last month. But the other two, focused on heart failure and respiratory conditions like flu, respectively, have not...
September 30, 2020
A research programme led by US-based non-profit medical centre Mayo Clinic and UK health tech firm Ultromics will apply AI to forecast heart failure.
The team will use AI analysis of ultrasound heart scans to identify the markers of heart failure and alert doctors to potential heart failure.
WHY IT MATTERS
The aim is to develop a diagnostic and predictive tool that can reduce misdiagnosis and...
September 14, 2018
This morning maker of heart failure management and remote monitoring devices Endotronix scored $45 million in a Series D financing round led by LSP, with participation from Aperture Venture Partners, BioVentures Investors, Lumira Ventures, OSF Ventures, Seroba Life Sciences, SV Health Investors, Wanxiang Healthcare Investments, and an unnamed corporate investor.
“We are thrilled with the world-...
March 12, 2018
A new study, sponsored by the US Department of Veterans Affairs, applied wearable biosensors to post-acute heart failure patients and deployed FDA-cleared analytics from vendor physIQ to detect vital sign anomalies.
It demonstrated promising predictive power for artificial intelligence-based analytics in terms of sensitivity, specificity and early warning lead time – suggesting the potential to...
December 21, 2017
Intermountain Healthcare researchers have created a new app to monitor heart failure patients and identify when their condition becomes advanced.
The app monitors medical tests and health status and quickly alerts clinicians that the heart patient’s care needs have changed. When computer monitoring indicates a patient likely has advanced heart failure, the app automatically sends a secure email...
June 29, 2017
The Duke Clinical Research Institute, funded by a grant from Novartis, is launching a large-scale study to explore the effectiveness of mobile apps in the treatment of heart failure patients. The study, called Connect HF, is aiming to enroll 8,000 patients across 160 hospitals by the end of fall 2018, with results hoped for by the end of 2020.
"CONNECT HF is a clinical trial looking at different...
May 3, 2017
San Francisco-based ReThink Medical raised $3 million to develop a medical wearable to predict and prevent heart failure. The round was led by Emergent Medical with additional funding from Norwich Ventures and Launch Capital. The company is also operating with a previously-awarded NIH grant as well as a strategic partnership with Japanese medical device company Terumo Corporation, which includes...
May 1, 2017
Boston Children's Hospital is the latest to tackle the problem of continuity of care between a patient's doctor and any emergency room or urgent care center they might find themselves in. And they're testing the technology, from startup Position Health, in some of their smallest and most high risk patients.
"At Boston Children’s we have a population of very high risk infants with severe...
August 11, 2016
Medical technology company ImpediMed launched a direct-to-consumer connected device that tracks body composition, fluid status and hydration in a variety of settings.
SOZO is two-pound, sensor-enabled scale with a connected stand and platform cradle to rest either a tablet or smartphone. The users steps on the scale, which has eight body sensors and four weight sensors, waits a few seconds and...
July 14, 2016
Chicago-based Endotronix, which makes devices to manage heart failure and remotely monitor cardiac patients, has raised $32 million in new funding. Investors included BioVentures, SV Life Sciences, Lumira Capital, Aperture Venture Partners and OSF Ventures. Existing investors as well as an unnamed corporate investor also participated. This brings Endotronix's total funding to date to $50 million...